JPS63312398A - Production of fat and oil - Google Patents
Production of fat and oilInfo
- Publication number
- JPS63312398A JPS63312398A JP62149693A JP14969387A JPS63312398A JP S63312398 A JPS63312398 A JP S63312398A JP 62149693 A JP62149693 A JP 62149693A JP 14969387 A JP14969387 A JP 14969387A JP S63312398 A JPS63312398 A JP S63312398A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- glyceride
- acid
- oil
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 54
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 44
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 39
- 229930195729 fatty acid Natural products 0.000 claims abstract description 39
- 239000000194 fatty acid Substances 0.000 claims abstract description 39
- 239000002904 solvent Substances 0.000 claims abstract description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 16
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 14
- 238000004440 column chromatography Methods 0.000 claims abstract description 9
- 239000003054 catalyst Substances 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 238000005809 transesterification reaction Methods 0.000 claims description 18
- 239000004367 Lipase Substances 0.000 claims description 17
- 108090001060 Lipase Proteins 0.000 claims description 17
- 102000004882 Lipase Human genes 0.000 claims description 17
- 235000019421 lipase Nutrition 0.000 claims description 17
- -1 fatty acid ester Chemical class 0.000 claims description 7
- 125000005313 fatty acid group Chemical group 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000009826 distribution Methods 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 14
- 235000021588 free fatty acids Nutrition 0.000 abstract description 11
- 150000002148 esters Chemical class 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 6
- 235000019621 digestibility Nutrition 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 238000005192 partition Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004810 partition chromatography Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 33
- 235000019198 oils Nutrition 0.000 description 32
- 239000003925 fat Substances 0.000 description 29
- 235000019197 fats Nutrition 0.000 description 28
- 239000000203 mixture Substances 0.000 description 20
- 239000002253 acid Substances 0.000 description 15
- 239000002994 raw material Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000019485 Safflower oil Nutrition 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- 235000005713 safflower oil Nutrition 0.000 description 6
- 239000003813 safflower oil Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 125000004185 ester group Chemical group 0.000 description 5
- 235000014593 oils and fats Nutrition 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229960002446 octanoic acid Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- HBOQXIRUPVQLKX-UHFFFAOYSA-N linoleic acid triglyceride Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010048733 Lipozyme Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000003622 immobilized catalyst Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000010913 used oil Substances 0.000 description 1
Landscapes
- Edible Oils And Fats (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【発明の詳細な説明】
Tal産業上の利用分野
本発明はグリセリドの2位の脂肪酸残基の炭素数が1位
または3位の脂肪酸残基の炭素数に比較して鎖長が大き
い新規な特殊構造油脂の製造法に関する。本発明で得ら
れる特殊構造油脂は医薬分野、食品分野などで利用され
る。DETAILED DESCRIPTION OF THE INVENTION Field of industrial application of Tal The present invention is directed to a novel glyceride in which the chain length of the fatty acid residue at the 2nd position is larger than that of the fatty acid residue at the 1st or 3rd position. Concerning a method for producing special structured fats and oils. The special structure oil and fat obtained by the present invention is used in the pharmaceutical field, food field, etc.
(bl従来の技術
従来、食用や医薬用をはじめ種々の産業で利用されてい
る油脂は、主として動植物などの組織から単離、精製さ
れたものであり、そのグリセリドの成分構成は各種脂肪
酸がいわゆるランダム分布している混合物である。一方
、大豆油、ナタネ油、サフラワー油などに代表される植
物系油脂は必須脂肪酸であるリノール酸を多く含み、ま
た牛脂、魚油のような動物系油脂は短鎖およびC16以
上の高度不飽和脂肪酸(EPA:エイコサペンクエン酸
、DHA ニドコサヘキサエン酸など)を含むなどの特
色をもっている。特にリノール酸が血清コレステロール
の低下効果をもつこと、EPAやDHAが血小板凝集抑
制作用や血清コレステロール低下作用を有し、脳血栓の
予防効果をもつことなどから、近年これらの長鎖高度不
飽和脂肪酸の摂取が健康の維持に重要であることが強調
されている。そのため、サフラワー油や魚油精製品が各
種食品に使用されるケースが増えているが、これらの脂
肪酸を多く含む油脂の消化吸収性はあまり良いとはいえ
ない。特に病人や老人のように消化機能が衰えた人々に
とっては消化吸収性の問題はさらに大きくなる。(bl Conventional Technology) Oils and fats used in various industries, including food and medicine, are mainly isolated and purified from the tissues of animals and plants, and the composition of their glycerides consists of various fatty acids. It is a randomly distributed mixture.On the other hand, vegetable oils such as soybean oil, rapeseed oil, and safflower oil contain a lot of linoleic acid, an essential fatty acid, and animal oils such as beef tallow and fish oil contain It has the characteristics of containing short chain and highly unsaturated fatty acids of C16 or higher (EPA: eicosapen citric acid, DHA: nidocosahexaenoic acid, etc.).In particular, linoleic acid has a serum cholesterol lowering effect, and EPA and DHA In recent years, it has been emphasized that the intake of these long-chain polyunsaturated fatty acids is important for maintaining health because they inhibit platelet aggregation, lower serum cholesterol, and prevent cerebral thrombosis. Increasingly, safflower oil and fish oil refined products are used in various foods, but the digestibility of these fatty acid-rich oils and fats is not very good.Especially in cases where the digestive function of the sick and elderly is impaired. Digestive and absorption problems become even more serious for people who have a weakened body.
一方、このような長鎖脂肪酸に対して、炭素数が8〜1
2程度の比較的短い脂肪酸から成る油脂、すなわち中鎖
脂肪酸グリセリド(MCT)が、非常に吸収も早く、代
謝もされ易いことが知られており、流動食の脂質源など
として利用されている。On the other hand, for such long-chain fatty acids, the number of carbon atoms is 8 to 1.
It is known that fats and oils consisting of relatively short fatty acids of about 2, ie, medium-chain fatty acid glycerides (MCT), are absorbed very quickly and are easily metabolized, and are used as a lipid source for liquid foods.
しかし、MCTはその急速な吸収および代謝に伴う消化
器管の不調(下痢など)や、多量摂取時のケトン体の生
成などの副作用を生しることも多かった。このようにエ
ネルギー源としてMCTを多用することは困難なため、
MCTとLCT(長鎖脂肪酸トリグリセリド)を併用す
ること、すなわち両者の混合物、もしくは両者のランダ
ム・エステル基交換物が提案されているが、これらの方
法も消化吸収性の点でなお不十分であった。However, MCT often causes side effects such as gastrointestinal complaints (diarrhea, etc.) due to its rapid absorption and metabolism, and the production of ketone bodies when ingested in large amounts. Because it is difficult to use MCT extensively as an energy source,
It has been proposed to use MCT and LCT (long chain fatty acid triglyceride) together, that is, a mixture of both, or a random transesterification product of both, but these methods are still insufficient in terms of digestibility and absorption. Ta.
また、上記の長鎖高度不飽和脂肪酸は酸化、劣化、変性
しやすく、他の油脂類との単なる混合物あるいはランダ
ム・エステル基交換物では満足できるものは得られてい
ない。In addition, the long-chain highly unsaturated fatty acids mentioned above are easily oxidized, degraded, and modified, and no satisfactory product has been obtained from mere mixtures with other fats and oils or from random ester exchange products.
一方、エステル交換の手段としては1.3位特異性リパ
ーゼを用いる方法が知られており、例えばグリセリドと
脂肪酸を通常、ヘキサンなどの有機溶剤の共存下に混合
し、これに酵素が機能を発現するための少量の水分を付
与したリパーゼを共存させ、数時間ないし数十時間、静
置あるいは攪拌し、あるいは該リパーゼを支持担体に吸
着または結合させた固定リパーゼと接触させる。On the other hand, a method using 1.3-specific lipase is known as a means of transesterification. For example, glyceride and fatty acid are usually mixed in the coexistence of an organic solvent such as hexane, and the enzyme expresses the function. Lipase to which a small amount of water has been added for the purpose of hydration is allowed to coexist, and the lipase is left standing or stirred for several hours to several tens of hours, or the lipase is brought into contact with immobilized lipase adsorbed or bonded to a support carrier.
かかる反応により、一方の原料であるグセリドの脂肪酸
残基は他方の原料である遊離脂肪酸残基と置換し、エス
テル基交換反応物が得られるが、該反応物は実際的には
未反応物、グリセリドの1位もしくは3位交換物、1位
および3位交換物のほかに1位および2位交換物、2位
および3位交換物、1位および2位および3位交換物、
さらに加水分解物と推定されるジグリセリドやモノグリ
セリドを含有し、さらにエステル基交換反応が平衡反応
であるがために原料の遊離脂肪酸とエステル基交換反応
により生成する遊離脂肪酸とが共存する複雑な混合組成
物となる。かかる組成物からグリ↓リドの1位および3
位交換物のみを単離する方法としては、従来、アルカリ
洗浄、蒸留、イオン交換樹脂処理、シリカゲルカラムク
ロマドグ=5−
ラフイー等により遊離脂肪酸、さらには部分グリセリド
を除去した後、グリセリドの融点などの物性の差を応用
した溶剤もしくは無溶剤分別により目的とするグリセリ
ドを得るものであった。Through such a reaction, the fatty acid residues of one raw material, glyceride, are substituted with the free fatty acid residues of the other raw material, and a transesterification reaction product is obtained, but the reaction product is actually unreacted products, 1st or 3rd place exchanged products of glycerides, 1st and 2nd place exchanged products, 2nd and 3rd place exchanged products, 1st and 2nd and 3rd place exchanged products in addition to the 1st and 3rd place exchanged products,
Furthermore, it contains diglycerides and monoglycerides that are presumed to be hydrolysates, and since the transesterification reaction is an equilibrium reaction, it has a complex mixture composition in which the free fatty acids of the raw material and the free fatty acids produced by the transesterification coexist. Become a thing. From such a composition, Glylide 1 and 3
Conventionally, methods for isolating only position-exchanged products include removing free fatty acids and partial glycerides using alkali washing, distillation, ion exchange resin treatment, silica gel column chromatography, etc., and then measuring the melting point of the glyceride. The desired glyceride was obtained by solvent or solvent-free fractionation that took advantage of the differences in physical properties.
しかしながら、旧来のアルカリ洗浄法では操作中の乳化
現象のために目的成分の損失が大きく、また水蒸気蒸留
や分子蒸留ではその処理による熱履歴のため短鎖ないし
中鎖脂肪酸を利用する場合には、グリセリド間あるいは
グリセリドと共存する遊離脂肪酸との間で脂肪酸基の熱
転移がおき、特に1位および3位のエステル基交換反応
物ではグリセリドの位置、特異性のある成分が得られ難
いという大きな欠点をもち、イオン交換樹脂処理では操
作時のpH変動による同様の現象がおき、さらにシリカ
ゲル等のカラムクロマトグラフィーでは大量の複雑な混
合溶剤を使用せねばならず、また、多量の遊離脂肪酸が
共存する場合には処理量に限界がありコスト高にならざ
るを得ないなどの諸々の欠点を有していた。またグリセ
リド組成の分画において、溶剤を使用あるいは使用せず
分別する方法では主として各成分の融点差を利用するも
のであるが、2種以上の成分が共存する場合にはそれら
の間で融点降下現象を示し、各成分の混合比率とも相ま
って分別のための温度コントロールは極めて微妙な操作
方法を必要とし、また単一の操作では高純度の目的成分
が得難く、したがって設備・装置が大型化せざるを得な
いという産業的な利用を考慮する際、極めて大きな欠点
を有している。However, in conventional alkaline cleaning methods, there is a large loss of target components due to emulsification phenomenon during operation, and in steam distillation and molecular distillation, due to the heat history caused by the processing, when using short-chain to medium-chain fatty acids, A major drawback is that thermal transfer of fatty acid groups occurs between glycerides or between glycerides and free fatty acids coexisting with the glycerides, and it is difficult to obtain components that are specific to the position of the glyceride, especially in the case of 1- and 3-position transesterification products. In ion exchange resin treatment, a similar phenomenon occurs due to pH fluctuations during operation, and in column chromatography such as silica gel, large amounts of complex mixed solvents must be used, and large amounts of free fatty acids coexist. In some cases, it has various disadvantages such as a limited amount of processing and an unavoidable increase in cost. In addition, in the fractionation of glyceride composition, methods that use or do not use solvents mainly utilize the difference in melting point of each component, but when two or more components coexist, the melting point decreases between them. In conjunction with the mixing ratio of each component, temperature control for separation requires extremely delicate operation methods, and it is difficult to obtain highly pure target components with a single operation, so the equipment and equipment must be large. When considering industrial use, which is unavoidable, it has an extremely large drawback.
(C1発明が解決しようとする問題点
本発明の目的は、医薬品分野、食品分野において利用で
きる、安定性の良いしかも消化吸収性の極めて優れた新
規な特殊構造の油脂を製造するにあたり、従来の欠点や
不十分な効果を解決した新規な製造方法を提供すること
にある。(C1 Problems to be Solved by the Invention The purpose of the present invention is to solve the problem of conventional fats and oils in the production of a novel special structure of fats and oils that can be used in the pharmaceutical and food fields, have good stability, and are extremely digestible and absorbable. The object of the present invention is to provide a new manufacturing method that solves the drawbacks and insufficient effects.
fd1問題点を解決するための手段
すなわち本発明はグリセリドの1.3位の脂肪酸残基の
炭素数が2〜16であり、2位の脂肪酸残基の炭素数が
8以上でありかつ、2位の脂肪酸残基の炭素数が1.3
位の脂肪酸残基の炭素数よりも大きい油脂の製造にあた
り、■グリセリドとグリセリド、脂肪酸または脂肪酸エ
ステルとを1゜3位特異性のある触媒の存在下でエステ
ル基交換反応させること、■必要に応じてそのエステル
基交換反応物を含水溶剤で処理することにより遊離脂肪
酸および/または部分グリセリドを除去すること、およ
び■エステル基交換反応物またはその含水溶剤処理物を
逆相型分配カラムクロマトグラフィーで分画することか
らなる前記油脂の製造法に関するものである。A means for solving the fd1 problem, that is, the present invention, is that the fatty acid residue at the 1.3-position of the glyceride has 2 to 16 carbon atoms, the fatty acid residue at the 2-position has 8 or more carbon atoms, and The number of carbon atoms in the fatty acid residue at position is 1.3
In the production of fats and oils having a carbon number larger than the number of carbon atoms in the fatty acid residue at position 1, it is necessary to: Accordingly, free fatty acids and/or partial glycerides are removed by treating the transesterified product with a water-containing solvent, and ■ the transesterified product or its water-containing solvent-treated product is subjected to reversed-phase distribution column chromatography. The present invention relates to a method for producing the oil and fat, which comprises fractionation.
本発明における1、3位の脂肪酸はその残基の炭素数が
2〜16であり、また2位の脂肪酸はその残基の炭素数
が8以上であることを要するが、これらに該当するもの
であれば飽和および不飽和脂肪酸のいずれでもよく、ま
た幾何異性体、側鎖状異性体等を含んでいてもよい。ま
た炭素数が偶数または奇数の脂肪酸でも本発明は何ら影
響を受けることはない。これらの脂肪酸の例としては酢
酸、酪酸、カプロン酸、カプリル酸、2−ニーf−)L
iヘキサン酸、カプリン酸、ラウリン酸、ミリスチン酸
、ペンタデカン酸、パルミチン酸、パルミトオレイン酸
、ステアリン酸、イソステアリン酸、オレイン酸、エラ
イジン酸、リノール酸、α−リルン酸(18:3. ω
3.all−cisΔ9+ 12+ I5)、γ−リル
ン酸(18:3. ω6.all−cisA6−+9+
+2) 、7 ’−リルン酸(18:3. ω6.al
l−cisΔ5°9+12)、ベヘン酸、エルシン酸、
アラキドン酸、エイコサペンクエン酸、ドコサヘキサエ
ン酸などが使用できる。これらの脂肪酸は目的とする油
脂の性状、生理あるいは栄養効果などにより、適宜、単
独あるいは組み合わせて各種のものを用いることができ
るが、油脂の安定性から1.°3位に飽和型、2位に不
飽和型脂肪酸を配列させたものが望ましい。In the present invention, the fatty acids at the 1st and 3rd positions must have a residue of 2 to 16 carbon atoms, and the fatty acid at the 2nd position must have a residue of 8 or more carbon atoms. The fatty acids may be either saturated or unsaturated, and may include geometric isomers, side chain isomers, and the like. Furthermore, the present invention is not affected by fatty acids having an even or odd number of carbon atoms. Examples of these fatty acids are acetic acid, butyric acid, caproic acid, caprylic acid, 2-nif-)L
iHexanoic acid, capric acid, lauric acid, myristic acid, pentadecanoic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, linoleic acid, α-lylunic acid (18:3. ω)
3. all-cisΔ9+ 12+ I5), γ-lylunic acid (18:3.ω6.all-cisA6-+9+
+2), 7'-lylunic acid (18:3.ω6.al
l-cisΔ5°9+12), behenic acid, erucic acid,
Arachidonic acid, eicosapencitric acid, docosahexaenoic acid, etc. can be used. Various types of these fatty acids can be used individually or in combination as appropriate depending on the properties, physiology, or nutritional effects of the target oil or fat, but 1. ° It is desirable to have a saturated fatty acid in the 3rd position and an unsaturated fatty acid in the 2nd position.
また、本発明に係わるグリセリドはグリセリドの各位置
に結合する脂肪酸において、2位の脂肪酸残基の炭素数
が1または3位のそれに比較して大きいことを特定して
いる。これは、上述の各種脂肪酸を適宜、選択して以下
に述べる方法で製造することができるが、その例として
は1.3−シカブリロー2−リルイン、1.3−ジバル
ミトー2−リルイン、1−力ブリ口−2−オレオ−3−
ラウリン、1,3−シカプロー2−エイコサペンクエン
酸グリセリド等があげられる。Furthermore, in the glyceride according to the present invention, it is specified that among the fatty acids bonded to each position of the glyceride, the number of carbon atoms in the fatty acid residue at the 2nd position is larger than that at the 1st or 3rd position. This can be produced by the method described below by appropriately selecting the various fatty acids mentioned above. Yellowtail-2-Oreo-3-
Examples include laurin, 1,3-cicapro 2-eicosapene citrate glyceride, and the like.
かかる特殊構造油脂を製造する上での特徴の1つは、グ
リセリドとグリセリドまたは脂肪酸または脂肪酸エステ
ルとを1.3位特異性のある触媒の存在下でエステル基
交換反応させることにある。One of the features of producing such special structured fats and oils is that glyceride and glyceride or fatty acid or fatty acid ester are subjected to a transesterification reaction in the presence of a catalyst having specificity for the 1.3-position.
原料とすべきグリセリドは合成品または天産品のいずれ
でもよく、例えば上述の各種脂肪酸の単酸基および/ま
たは混酸基グリセリドが使用でき、また大豆油、ナタネ
油、ゴマ油、サフラワー油、ひまわり油、コーン油、パ
ーム油などの植物系油脂や牛脂、ラード、魚油などの動
物系油脂を用いることができる。なお、これらのグリセ
リドはジグリセリド″等の部分グリセリドを含んでいて
も差し支えない。さらに本発明の原料として使用するグ
リセリドは少なくともその一方のグリセリドの2位の脂
肪酸の50%以上が同一種類のものであることが望まし
い。これらの例としては合成品では前述の単酸基および
混酸基グリセリド等、天産品ではオレイックサフラワー
油、オレイツクひまわり油、茶油等、また前述の動植物
系油脂の分別等による分画物などが利用できる。原料と
すべき脂肪酸の種類と前述の例などから目的とすべき特
殊構造油脂のグリセリド組成に見合った鎖長、および不
飽和度の脂肪酸を適宜選択して使用することができる。The glyceride to be used as a raw material may be either a synthetic product or a natural product. For example, monoacid group and/or mixed acid group glycerides of the various fatty acids mentioned above can be used, and soybean oil, rapeseed oil, sesame oil, safflower oil, and sunflower oil can be used. Vegetable fats and oils such as , corn oil and palm oil, and animal fats and oils such as beef tallow, lard and fish oil can be used. Note that these glycerides may contain partial glycerides such as diglyceride.Furthermore, at least 50% or more of the fatty acids at the 2nd position of at least one of the glycerides used as the raw material of the present invention are of the same type. Examples of these include synthetic products such as the aforementioned monoacid group and mixed acid group glycerides, natural products such as oleic safflower oil, oleic sunflower oil, tea oil, etc., and the aforementioned fractionation of animal and vegetable oils and fats. Based on the type of fatty acid to be used as a raw material and the above-mentioned examples, select a fatty acid with a chain length and degree of unsaturation appropriate to the glyceride composition of the target special structured oil and fat. can do.
また原料とすべき脂肪酸エステルは、上述の任意の脂肪
酸の1価および/または2価の低級アルコールエステル
、すなわち該脂肪酸のメチル、エチル、プロピル、イソ
プロピル、ブチル等の各モノアルコールエステルまたは
エチレングリコール、プロピレングリコール、1.3−
ブタンジオールなどの各ジオールエステル等が利用でき
る。かかる原料であるグリセリドとグリセリドまたは脂
肪酸または脂肪酸エステルとをグリセリド間反応、およ
びグリセリドと脂肪酸ジエステルとの反応のには1モル
:1〜5モル、好ましくは1モル:2〜3モル、グリセ
リドと脂肪酸または脂肪酸モノエステルとの反応の場合
には1モル:2〜7モル、好ましくは1モル:3〜5モ
ルの割合で原料を混合する。この範囲を外れる原料配合
比率だと反応が十分に進行しなかったり、また反応が進
みすぎて2位交換体が多量に副生ずるので好ましくない
。これをエステル基交換反応に必要な所定温度にて水分
を飽和させた後、1.3位特異性のある触媒を添加し、
攪拌、あるいは該触媒を実質的にエステル基交換反応に
関与しない固定支持体に固定化した固定化触媒に接触さ
せ(例えば固定化触媒を充填したカラム内に原料を連続
的に通液して)、溶剤存在下または無溶剤下においてエ
ステル基反応を行なわせしめる。ここで、1゜3位特異
性のある触媒としては、LIPOZYME (NOVO
社製)、タリパーゼ(田辺製薬側製)、リパーゼ(生化
学工業■製)、リパーゼD、リパーゼF−AP、リパー
ゼM、リパーゼAP、リパーゼR、ニューラーゼ(以上
天野製薬■製)などの市販品を用いることができる。In addition, the fatty acid ester to be used as a raw material is monovalent and/or divalent lower alcohol ester of any of the above-mentioned fatty acids, that is, each monoalcohol ester of the fatty acid such as methyl, ethyl, propyl, isopropyl, butyl, or ethylene glycol, Propylene glycol, 1.3-
Diol esters such as butanediol can be used. For the interglyceride reaction of such raw materials, glyceride and glyceride or fatty acid or fatty acid ester, and the reaction of glyceride and fatty acid diester, 1 mol: 1 to 5 mol, preferably 1 mol: 2 to 3 mol, glyceride and fatty acid. Alternatively, in the case of reaction with fatty acid monoester, the raw materials are mixed at a ratio of 1 mol:2 to 7 mol, preferably 1 mol:3 to 5 mol. If the mixing ratio of the raw materials is outside this range, the reaction may not proceed sufficiently, or the reaction may proceed too much, resulting in a large amount of 2-position exchanger being produced as a by-product, which is not preferable. After saturating this with water at a predetermined temperature necessary for the transesterification reaction, a catalyst with specificity at the 1.3 position is added,
Stirring or bringing the catalyst into contact with an immobilized catalyst immobilized on a fixed support that does not substantially participate in the transesterification reaction (for example, by continuously passing the raw material through a column packed with the immobilized catalyst) , the ester group reaction is carried out in the presence of a solvent or in the absence of a solvent. Here, LIPOZYME (NOVO
Commercial products such as Talipase (manufactured by Tanabe Seiyaku), Lipase (manufactured by Seikagaku Corporation), Lipase D, Lipase F-AP, Lipase M, Lipase AP, Lipase R, Neurase (manufactured by Amano Pharmaceutical), etc. products can be used.
本発明の他の特徴の1つは、かかる反応で得られる性成
物である混合成分から遊離脂肪酸および/または部分グ
リセリドを効率的に除去する手段であり、該反応物を含
水溶剤で洗浄処理するものである。すなわち、エステル
基交換反応物に対し、含水率が5〜95%、好ましくは
10〜80%、さらに望ましくは10〜70%の含水溶
剤を0.5〜20重量倍、望ましくは2〜5N量倍添加
、攪拌し、−10〜60℃、望ましくは0〜10℃で静
置後、デカンテーションにより層分離することにより、
遊離脂肪酸および/または部分グリセリドを驚異的に除
去することができ、またトリグリセリドの損失も少なく
、熱処理による着色、グリセリドの脂肪酸、殊に短鎖な
いし中鎖脂肪酸はもとより長鎖脂肪酸の転位もおきない
という大きなメリットがある。ここで含水溶剤として使
用できる溶剤の種類は水と均一に混合、溶解するもので
あれば特に制限はないが、炭素数8以下の直鎖状アルコ
ールすなわち、メタノール、エタノール、プロパツール
、ブタノール、ヘキサノール、オクタツールなどが好ま
しい。Another feature of the present invention is a means for efficiently removing free fatty acids and/or partial glycerides from a mixed component, which is a reaction product obtained by such a reaction, by washing the reaction product with a water-containing solvent. It is something to do. That is, a water-containing solvent having a water content of 5 to 95%, preferably 10 to 80%, more preferably 10 to 70% is added 0.5 to 20 times by weight, preferably in an amount of 2 to 5 N, based on the transesterification reaction product. By adding twice as much, stirring, leaving to stand at -10 to 60°C, preferably 0 to 10°C, and separating the layers by decantation,
Free fatty acids and/or partial glycerides can be removed to a remarkable degree, there is little loss of triglycerides, there is no coloration due to heat treatment, no rearrangement of fatty acids in glycerides, especially short-chain to medium-chain fatty acids, as well as long-chain fatty acids. There is a big advantage. The types of solvents that can be used as the water-containing solvent are not particularly limited as long as they can be uniformly mixed and dissolved in water, but linear alcohols with 8 or less carbon atoms, i.e., methanol, ethanol, propatool, butanol, hexanol , octatool, etc. are preferred.
なお、この手段は必要に応じて採用することができる。Note that this means can be adopted as necessary.
−13〜
本発明のさらに他の特徴の−っは、かがる含水溶剤処理
で精製したトリグリセリド組成物またはエステル基交換
反応物そのものから目的とするグリセリドを分画する手
段であり、逆相型分配カラムクロマトグラフィーを用い
て分画するものである。カラムに充填する樹脂としては
シラノール基(SiOH)をオクタデシル基あるいはオ
クチル基などで化学修飾したシリカゲル系吸着剤が利用
でき、例えばオクタデカシラン(ODS)(山村化学研
究断裂)、アミノプロピル基をカップリング付加反応さ
せたシリカゲル(伊勢化学■製)などの市販品が使用で
きるが、ODSが実際上好ましい。-13~ Still another feature of the present invention is a means for fractionating the target glyceride from the triglyceride composition purified by the water-containing solvent treatment or the transesterification product itself, and is a reversed-phase type. It is fractionated using partition column chromatography. As the resin to fill the column, silica gel-based adsorbents in which silanol groups (SiOH) are chemically modified with octadecyl or octyl groups can be used. Commercially available products such as ring addition-reacted silica gel (manufactured by Ise Kagaku ■) can be used, but ODS is practically preferred.
溶離液としてはアクリロニトリル、水、メタノール、エ
タノールなど種々の溶媒を単独もしくは2種以上の混合
溶剤として用いることができるが、エタノール/アセト
ン−971〜1’/9(v/v)、好ましくはエタノー
ル/アセトン−971〜6/4(ν/v)の混合溶剤を
使用するのが経済的である。該カラム処理で分画したグ
リセリド成分は極めて淡色なもので最高純度100%ま
で高めることができるが、目的用途に応じて適宜純度を
調節することも可能である。As the eluent, various solvents such as acrylonitrile, water, methanol, and ethanol can be used alone or as a mixed solvent of two or more, but ethanol/acetone-971-1'/9 (v/v), preferably ethanol It is economical to use a mixed solvent of /acetone-971 to 6/4 (v/v). The glyceride component fractionated by this column treatment is extremely pale in color and can be increased in purity up to 100%, but the purity can be adjusted as appropriate depending on the intended use.
本発明によって得られる特殊構造油脂は、同比率の脂肪
酸基を有する混合グリセリドやランダム・エステル基交
換反応物等に比較して酸化安定性に極めて優れているこ
とがみとめられた(表−1参照)。It was found that the special structured fats and oils obtained by the present invention have extremely superior oxidative stability compared to mixed glycerides having the same proportion of fatty acid groups, random transesterification products, etc. (see Table 1). ).
=15〜
本発明の油脂は脂肪乳剤輸液、経腸栄養剤の油脂成分と
してとくに好適であり、その他座薬の基剤などの油脂成
分としても有用である。=15~ The fat and oil of the present invention is particularly suitable as a fat and oil component for fat emulsion infusions and enteral nutrients, and is also useful as a fat and oil component for other bases of suppositories.
さらに本発明の油脂は常温で通常液体であるため、ドレ
ッシング、マヨネーズに使ったり、流動状の治療用食品
の油脂成分として利用できる。Furthermore, since the fats and oils of the present invention are normally liquid at room temperature, they can be used in dressings, mayonnaise, or as fats and oils components in liquid therapeutic foods.
また、水産、畜産用飼料に添加する油脂としても本発明
の油脂は使用できる。即ち、哺乳類や魚類は一般的に幼
少期における消化、吸収、代謝能力が弱く、適正な油脂
の投与を行わないと下痢などの障害が出ることがある。Furthermore, the fats and oils of the present invention can also be used as fats and oils added to feed for fisheries and livestock. That is, mammals and fish generally have weak digestive, absorption, and metabolic abilities during their childhood, and if appropriate fats and oils are not administered, problems such as diarrhea may occur.
従って、このような場合にも本発明のグリセリドを用い
ると効果的である。Therefore, it is effective to use the glyceride of the present invention in such cases as well.
tel実施例
実施例1
サフラワー油をケン化分解して得られる混合脂肪酸を尿
素、メタノール付加物法で処理し、さらに蒸留して高純
度リノール酸(GLC純度:99.2%)を得た。これ
をグリセリンと混合し、常法によりエステル化、脱酸、
脱色および脱臭の各端製処理をしてリノール酸トリグリ
セリドを得た。tel Examples Example 1 Mixed fatty acids obtained by saponification and decomposition of safflower oil were treated with urea and methanol adduct method, and further distilled to obtain high purity linoleic acid (GLC purity: 99.2%) . Mix this with glycerin, esterify, deacidify, and
Linoleic acid triglyceride was obtained by decolorizing and deodorizing the ends.
このリノール酸トリグリセリド1モルに対しカプリン酸
(ヘンケル社製;GLC純度99.5%)3モルを混合
し、40℃で水分を飽和させ、原料に対してl Qwt
%のリパーゼ(田辺製薬■製:タリパーゼ)を添加して
40〜45℃で10時間攪拌した。反応後、酵素蛋白質
等を加温、濾過処理により除き、エステル基交換反応粗
生成物(酸価=76)を得た。3 moles of capric acid (manufactured by Henkel; GLC purity 99.5%) are mixed with 1 mole of this linoleic acid triglyceride, saturated with water at 40°C, and 1 Qwt relative to the raw material is mixed.
% of lipase (Talipase, manufactured by Tanabe Seiyaku ■) was added and stirred at 40 to 45°C for 10 hours. After the reaction, enzyme proteins and the like were removed by heating and filtration to obtain a crude transesterification reaction product (acid value = 76).
次に該反応物に対して4重量倍の含水率20%エタノー
ル溶液を加え、攪拌後、5°Cに静置してから油層を分
離した。この含水エタノール洗浄物の酸価は0.5であ
った。Next, 4 times the weight of an ethanol solution with a water content of 20% was added to the reaction product, and after stirring, the mixture was allowed to stand at 5°C, and then the oil layer was separated. The acid value of this water-containing ethanol-washed product was 0.5.
さらに該エタノール洗浄物をオクタデカシラン(ODS
;山村化学研究断裂 YMC−ODS。Furthermore, the ethanol-washed product was washed with octadecasilane (ODS).
; Yamamura Chemical Research Disruption YMC-ODS.
60A 30/210μm)を充填したカラムで溶離
液としてエタノール/アセトン−9/ 1 (v/v)
を通液して各フラクションに分取し、目的とする新規な
特殊構造油脂である1、3−シカブロー2−リルイン(
10・し・10と略す)を得た。この油脂の組成を表−
3に示す。Ethanol/acetone-9/1 (v/v) as eluent in a column packed with 60A 30/210 μm)
The liquid is passed through the liquid, separated into each fraction, and 1,3-cicabro-2-riruin (
10・shi・10) was obtained. The composition of this oil and fat is shown below.
Shown in 3.
表−3特殊構造油脂(10・L・10)の組成性)L:
リノール酸
実施例2
オレイック・サフラワー油(総脂肪酸中オレイン酸含量
ニア6.0%、2位脂肪酸中オレイン酸含量80.5%
)1モルと中鎖トリグリセリド(カプリル酸/カプリン
酸−75/25のランダム・エステル化物)2モルとを
混合し、60〜65℃で水分を飽和させ、エステル基交
換反応の原料とした。一方、内径5cmおよび長さ50
cmのステンレス製円管に固定化リパーゼ(NOVO社
製 LIPOZYME)を充填し、上述の原料を5 Q
m 127時の流速で通過させエステル基交換反応を
行なわせしめた。Table-3 Composition of special structure oil (10・L・10) L:
Linoleic acid Example 2 Oleic safflower oil (oleic acid content in total fatty acids: 6.0%, oleic acid content in 2-position fatty acids: 80.5%)
) and 2 moles of medium-chain triglyceride (a random ester of caprylic acid/capric acid - 75/25) were mixed, saturated with water at 60 to 65°C, and used as a raw material for transesterification reaction. On the other hand, inner diameter 5cm and length 50
Immobilized lipase (LIPOZYME manufactured by NOVO) was filled in a stainless steel circular tube of 5 cm in size, and the above raw materials were added to the tube for 5 Q.
The transesterification reaction was carried out by passing the mixture at a flow rate of 127 m.
該反応物は酸価:6.5、水酸基価=9.7、全グリセ
リド中の1.3位エステル基交換体すなわち1,3−シ
カプリロー2−オレイン(8・0・8)、■、3−シカ
プロー2−オレイン(10・0・10)および1−カプ
リロ−2−オシレオ−3カプリン(8・0・10)の含
量:38.4%であった。The reactant has an acid value of 6.5, a hydroxyl value of 9.7, and an ester group exchanged at the 1.3 position in all glycerides, that is, 1,3-cicaprylo-2-olein (8.0.8), ■, 3 - Content of cicapro-2-olein (10.0.10) and 1-caprylo-2-osireo-3-caprin (8.0.10): 38.4%.
次に該反応物に対して2重量倍の含水率40%イソプロ
パツール溶液を加え、攪拌後、5°Cに静置して油層を
分離した。この含水溶剤による洗浄物の酸価は0.1で
あった。Next, 2 times the weight of an isopropanol solution with a water content of 40% was added to the reactant, and after stirring, the mixture was left to stand at 5°C to separate the oil layer. The acid value of the product washed with this water-containing solvent was 0.1.
さらに該洗浄物を実施例1と同様にODSカラムクロマ
トグラフィーで分画し、目的とする新規な特殊構造油脂
である8・0・8.10・0・1oおよび8・0・10
を得た。この油脂の組成を表−4に示す。Further, the washed product was fractionated by ODS column chromatography in the same manner as in Example 1, and the target novel special structure oils and fats were 8.0.8.10.0.1o and 8.0.10.
I got it. The composition of this oil and fat is shown in Table 4.
21 一
実施例3
海産クロレラ(C,minutissima)の培養細
胞からエイコサペンクエン酸を高含有する糖脂質(モノ
および/またはジガラクトシルジグリセリド)を得、常
法により糖鎖を酸分解して構成脂肪酸が12:O(1,
3%)、14:0(8,5%)、16:0(1,8%)
、16:H3,0%) 18:O(1,3%)、18:
Hl、3%)、18:2(1,5%)。21 Example 3 Glycolipids (mono- and/or digalactosyl diglycerides) containing a high amount of eicosapencitric acid were obtained from cultured cells of marine chlorella (C, minutissima), and the sugar chains were acid-decomposed using a conventional method. The fatty acid is 12:O(1,
3%), 14:0 (8.5%), 16:0 (1.8%)
, 16:H3,0%) 18:O(1,3%), 18:
Hl, 3%), 18:2 (1,5%).
20:4(4,1%) 、 20 : 5 (77、3
%)であるエイコサペンクエン酸を主成分とするジグリ
セリドを単離した。20:4 (4,1%), 20:5 (77,3
A diglyceride containing eicosapene citric acid as the main component was isolated.
このジグリセリド1モルに対し5モルのカプリル酸(ヘ
ンケル社製、GLC純度99.7%)を混合し、実施例
2と同様の処理によりエステル基交換反応物(酸価:
121水酸基価: 13.4.全グリセリド中の1.3
−シカプリロー2−エイコサペンクエン酸トリグリセリ
ドの含量:41.3%)を得た。5 moles of caprylic acid (manufactured by Henkel, GLC purity 99.7%) was mixed with 1 mole of this diglyceride, and treated in the same manner as in Example 2 to obtain an ester group exchange reaction product (acid value:
121 hydroxyl value: 13.4. 1.3 of total glycerides
-Cicaprilo 2-eicosapene citrate triglyceride content: 41.3%).
次に該反応物に対して5重量倍の含水率65%エタノー
ル溶液を加え、実施例2と同様の処理をして油層を分離
した。この洗浄物の酸価: 0.2.水酸基価:3.0
であった。Next, an ethanol solution with a water content of 65% was added to the reaction product in an amount of 5 times its weight, and the same treatment as in Example 2 was performed to separate the oil layer. Acid value of this washed product: 0.2. Hydroxyl value: 3.0
Met.
さらに該洗浄物を実施例1と同様にODSカラ一2ノー
ムクロマトグラフィーで分画し、目的とする新規特殊構
造油脂8・E・8を得た。この油脂の組成を表−5に示
す。Further, the washed product was fractionated by ODS Color 2 Norm chromatography in the same manner as in Example 1 to obtain the desired novel special structure fat 8.E.8. The composition of this oil and fat is shown in Table-5.
実施例4
リノール酸トリグリセリド(GLC純度: 99.5%
)、酢酸、リパーゼR(天野製薬■製)を用いて実施例
1と同様にエステル基交換反応物を得、含水率70%エ
タノール溶液を用いて脱酸後、ODSカラムクロマトグ
ラフィーでグリセリド成分を分画し、目的とする新規な
特殊構造油脂1,3−ジアセト2−リルイン(2・L・
2)を得た。この油脂の組成を表−6に示す。Example 4 Linoleic acid triglyceride (GLC purity: 99.5%
), acetic acid, and Lipase R (manufactured by Amano Seiyaku ■) to obtain an ester group exchange reaction product in the same manner as in Example 1. After deoxidizing using an ethanol solution with a water content of 70%, the glyceride component was removed by ODS column chromatography. Fractionate and target new special structured fats and oils 1,3-diaceto2-lyluine (2・L・
2) was obtained. The composition of this oil and fat is shown in Table-6.
表−6特殊構造油脂(2・L・2)の組成(f1発明の
効果
本発明の方法によれば、グリセリドの2位の脂肪酸がエ
ステル基交換反応した成分をほとんど含まず、はぼ完全
な1.3位エステル基交換体のみから成る抗酸化性の優
れた特殊構造の油脂が得られる。また、エステル基交換
反応物を含水溶剤で単に洗浄するのみで、共存する遊離
脂肪酸や部分グリセリドを除去することができる。さら
に逆相型分配カラムクロマトグラフィーで他のグリセリ
ド成分をほぼ完全に分離し、目的とする特殊構造の油脂
を高純度に精製することができる。Table 6 Composition of special structure oil (2・L・2) (f1 Effect of the invention According to the method of the present invention, the fatty acid at the 2-position of glyceride contains almost no component resulting from the transesterification reaction, and almost completely Oils and fats with a special structure with excellent antioxidation properties consisting only of the 1.3-position ester group-exchanged product can be obtained.Also, by simply washing the ester group-exchanged product with a water-containing solvent, coexisting free fatty acids and partial glycerides can be removed. In addition, other glyceride components can be almost completely separated using reversed-phase distribution column chromatography, and the target oil and fat with a special structure can be purified to a high degree of purity.
特許出願人 日清製油株式会社
手続補正書
昭和6さ7JB1日
1、事件の表示
昭和62年特許願第149693号
2、発明の名称
油脂の製造法
3、補正をする者
事件との関係 特許出願人
住所 東京都中央区新川−丁目23番1号本件に関す
る連絡は下記にお願いします。Patent Applicant Nisshin Oil Co., Ltd. Procedural Amendment Document 1986-7 JB1 Day 1, Indication of the Case 1988 Patent Application No. 149693 2, Name of the Invention Process for Manufacturing Oils and Fats 3, Person Making the Amendment Relationship to the Case Patent Application Address: 23-1 Shinkawa-chome, Chuo-ku, Tokyo For inquiries regarding this matter, please contact the address below.
郵便番号 221
住 所 神奈川県横浜市神奈用区6
名 称 日清製油株式会社 研究
雷 二工 nAFI (A 61)l’l”l!
4、補正の対象
(1)明細書の発明の詳細な説明の欄
5、補正の内容
(11明細書第5頁5行「固定リパーゼ」を「固定化リ
パーゼ」と訂正する。Postal code 221 Address 6, Kanayou-ku, Yokohama City, Kanagawa Prefecture Name Nisshin Oil Co., Ltd. Research Lightning 2nd Engineer nAFI (A 61)l'l"l!
4. Subject of amendment (1) Detailed explanation of the invention in the specification column 5, Contents of amendment (11. On page 5, line 5 of the specification, "immobilized lipase" is corrected to "immobilized lipase."
(2)同第5頁6行「グセリド」を「グリセリド」と訂
正する。(2) On page 5, line 6, "glyceride" is corrected to "glyceride."
(3)同第11頁下から4行「反応のには」を1反応の
場合には」と訂正する。(3) On page 11, line 4 from the bottom, ``For reactions'' should be corrected to read ``For one reaction.''
(4)同第16頁表−1中N004の試料名の欄に「中
鎖トリグリセリド(カプリル酸/カプリン酸−75/2
5の混合合脂肪酸のランダム・エステル化物)」とある
を「中鎖トリグリセリド(カプリル酸/カプリン酸=7
5/25の混合脂肪酸のランダム・エステル化物)」と
訂正する。(4) In the sample name column of N004 in Table 1 on page 16, “Medium chain triglyceride (caprylic acid/capric acid-75/2
Random esters of mixed fatty acids of
Random esterified product of mixed fatty acids of 5/25)" is corrected.
Claims (5)
〜16であり、2位の脂肪酸残基の炭素数が8以上であ
り、かつ2位の脂肪酸残基の炭素数が1、3位の脂肪酸
残基の炭素数よりも大きい油脂の製造にあたり、[1]
グリセリドとグリセリド、脂肪酸または脂肪酸エステル
とを1、3位特異性のある触媒の存在下にエステル基交
換反応させること、[2]必要に応じてそのエステル基
交換反応物を含水溶剤で処理することにより遊離脂肪酸
および/または部分グリセリドを除去すること、および
[3]エステル基交換反応物またはその含水溶剤処理物
を逆相型分配カラムクロマトグラフィーで分画すること
からなる前記油脂の製造法。(1) The number of carbon atoms in the fatty acid residues at positions 1 and 3 of glyceride is 2.
- 16, the number of carbon atoms in the fatty acid residue at the 2nd position is 8 or more, and the number of carbon atoms in the fatty acid residue at the 2nd position is larger than the number of carbon atoms in the fatty acid residues at the 1st and 3rd positions. [1]
Performing a transesterification reaction between glyceride and glyceride, fatty acid, or fatty acid ester in the presence of a catalyst having 1- and 3-position specificity, [2] Treating the transesterified product with a water-containing solvent as necessary. and [3] fractionating the transesterification reaction product or its water-containing solvent-treated product by reverse-phase distribution column chromatography.
脂肪酸である特許請求の範囲第1項記載の製造法。(2) The production method according to claim 1, wherein 50% or more of the fatty acids at position 2 of the glyceride are the same fatty acid.
請求の範囲第1項記載の製造法。(3) The production method according to claim 1, wherein the catalyst having 1- and 3-position specificity is a lipase.
直鎖状アルコールである特許請求の範囲第1項記載の製
造法。(4) The production method according to claim 1, wherein the water-containing solvent is a linear alcohol having 8 or less carbon atoms and a water content of 10 to 80%.
シルシリル化シリカゲルを用いるものである特許請求の
範囲第1項記載の製造法。(5) The production method according to claim 1, wherein the reversed-phase distribution column chromatography uses octadecylsilylated silica gel.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62149693A JP2603830B2 (en) | 1987-06-15 | 1987-06-15 | Production method of fats and oils |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62149693A JP2603830B2 (en) | 1987-06-15 | 1987-06-15 | Production method of fats and oils |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63312398A true JPS63312398A (en) | 1988-12-20 |
JP2603830B2 JP2603830B2 (en) | 1997-04-23 |
Family
ID=15480746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62149693A Expired - Fee Related JP2603830B2 (en) | 1987-06-15 | 1987-06-15 | Production method of fats and oils |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2603830B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003056928A1 (en) * | 2001-12-28 | 2003-07-17 | The Nisshin Oillio, Ltd. | Fat and oil compositions for decreasing blood lipid |
EP0965340A4 (en) * | 1996-12-23 | 2004-06-30 | Nippon Suisan Kaisha Ltd | Dermatologic preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60208940A (en) * | 1984-03-31 | 1985-10-21 | Nippon Zeon Co Ltd | Separation and purification of long-chain saturated acid |
JPS6195098A (en) * | 1984-07-06 | 1986-05-13 | ユニリ−バ− ナ−ムロ−ゼ ベンノ−トシヤ−プ | Production of interesterified oils and fats |
JPS61192798A (en) * | 1985-02-21 | 1986-08-27 | 工業技術院長 | Concentration for gamma-linolenic acid |
JPS62129389A (en) * | 1985-09-26 | 1987-06-11 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | Nutritive fat suitable for intestinal product and parenteralproduct |
-
1987
- 1987-06-15 JP JP62149693A patent/JP2603830B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60208940A (en) * | 1984-03-31 | 1985-10-21 | Nippon Zeon Co Ltd | Separation and purification of long-chain saturated acid |
JPS6195098A (en) * | 1984-07-06 | 1986-05-13 | ユニリ−バ− ナ−ムロ−ゼ ベンノ−トシヤ−プ | Production of interesterified oils and fats |
JPS61192798A (en) * | 1985-02-21 | 1986-08-27 | 工業技術院長 | Concentration for gamma-linolenic acid |
JPS62129389A (en) * | 1985-09-26 | 1987-06-11 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | Nutritive fat suitable for intestinal product and parenteralproduct |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0965340A4 (en) * | 1996-12-23 | 2004-06-30 | Nippon Suisan Kaisha Ltd | Dermatologic preparation |
WO2003056928A1 (en) * | 2001-12-28 | 2003-07-17 | The Nisshin Oillio, Ltd. | Fat and oil compositions for decreasing blood lipid |
US6827963B2 (en) | 2001-12-28 | 2004-12-07 | The Nisshin Oillio, Ltd. | Fats and oils composition for reducing lipids in blood |
Also Published As
Publication number | Publication date |
---|---|
JP2603830B2 (en) | 1997-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sivakanthan et al. | Current trends in applications of enzymatic interesterification of fats and oils: A review | |
KR100300826B1 (en) | Process for the Preparation of Materials with a High Content of Long Chain Polyunsaturated Fatty Acids | |
JP4175698B2 (en) | Novel triglyceride and composition containing the same | |
CN101356258B (en) | By the enzymatic reaction concentration of fatty acid alkyl esters with glycerine | |
Kapoor et al. | Importance and production of omega-3 fatty acids from natural sources. | |
JPH0412920B2 (en) | ||
JP2009084286A (en) | Functional acylglyceride | |
Speranza et al. | Lipase-mediated production of specific lipids with improved biological and physicochemical properties | |
WO2015024055A1 (en) | Separation of omega-3 fatty acids | |
Nagachinta et al. | Production and characterization of DHA and GLA-enriched structured lipid from palm olein for infant formula use | |
US5227403A (en) | Fats and oils having superior digestibility and absorptivity | |
Ferreira-Dias et al. | Bioprocess technologies for production of structured lipids as nutraceuticals | |
Zheng et al. | Enzymatic preparation of mono-and diacylglycerols: a review | |
JPH0923817A (en) | Oil-and-fat-containing food/beverage | |
WO2015050220A1 (en) | Oil/fat composition | |
JP3544246B2 (en) | Pharmaceutical composition for reducing blood lipid level | |
Hamam | Specialty lipids in health and disease | |
JPS63312398A (en) | Production of fat and oil | |
Christophe | Structural modified food fats: synthesis, biochemistry, and use | |
JP4276539B2 (en) | Cholesterol-lowering structural lipids containing omega-6 PUFA | |
JP3544247B2 (en) | Pharmaceutical composition for inhibiting platelet aggregation | |
Zhou et al. | Lipase‐catalyzed production of structured lipids via acidolysis of fish oil with caprylic acid | |
JP4850153B2 (en) | Novel triglyceride and composition containing the same | |
JP2004168985A (en) | Omega-3 type highly unsaturated fatty acid-containing partial glyceride composition and its production | |
Lie et al. | Esterification of polyunsaturated fatty acids with lipases from different sources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |